How Much Upside is Left in Abcam PLC Sponsored ADR (ABCM)? Wall Street Analysts Think 27.55%Zacks Investment Research • 05/23/23
Jonathan Milner Announces That He is Taking Steps to Call an Extraordinary General Meeting of Abcam ShareholdersGlobeNewsWire • 05/17/23
Lunaphore and Abcam Announce Agreement for Primary Antibody Validation for Use on COMET™, Combining Power of Trusted Antibody Provider With Superior Multiplex CapabilitiesBusiness Wire • 04/06/23
Abcam, plc Publication of 2022 Annual Report and Accounts and Notice of Annual General MeetingPRNewsWire • 03/30/23
NanoString and Abcam Expand Collaboration to Advance Spatial Multiomics ResearchBusiness Wire • 11/09/22
Wall Street Analysts Predict a 27% Upside in Abcam PLC Sponsored ADR (ABCM): Here's What You Should KnowZacks Investment Research • 03/18/22